JNJ dividend yield: 3.36%. ROP dividend yield: 4.00%. Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices. ROP is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in ROP shares.
Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.
ROP is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in ROP shares.
JNJ currently offers a 3.36% yield (4.96/share/year) while ROP offers 4.00% (2.00/share/year). ROP provides higher current income. However, JNJ has grown its dividend faster (5.8% 5Y CAGR), which may lead to better long-term income through compounding.
How much would $10,000 in JNJ vs ROP earn per year?
With $10,000 invested today: JNJ pays approximately $336/year. ROP pays approximately $400/year. With DRIP reinvestment over 10 years, these grow to $828/year (JNJ) and $899/year (ROP).
Does JNJ or ROP pay monthly dividends?
JNJ pays quarterly dividends. ROP pays quarterly dividends. Neither pay monthly — both use a quarterly schedule, which is preferred by investors who need regular cash flow.
📬
Get this JNJ vs ROP comparison by email
Save your analysis + get weekly dividend insights. Free forever.